CJC-1295 (no dac) 5mg + Ipamorelin 5mg

All compounds and related materials are supplied as a complete research package and are provided strictly for laboratory research use only. This includes all necessary related materials (such as bacteriostatic water, syringes, and accessories) for research preparation. They are not intended for human or veterinary use, medical diagnosis, treatment, or any form of self-administration.

CJC-1295 no DAC + Ipamorelin 5mg/5mg – Synergistic Growth Hormone Release Research Complex

CJC-1295 (no DAC) and Ipamorelin are two distinct research peptides that, when studied together, form one of the most examined combinations for growth hormone (GH) release dynamics. While CJC-1295 no DAC (MOD GRF 1-29) acts as a GHRH analog that triggers pituitary GH secretion, Ipamorelin functions as a selective GHRP (Growth Hormone Releasing Peptide) binding to ghrelin receptors. The result is a dual mechanism of GH release without prolactin or cortisol elevation — ideal for advanced endocrine and muscle-regeneration research. Supplied as a lyophilized (freeze-dried) peptide complex to preserve full stability and bioanalytical integrity during laboratory storage and handling.

Historical Background and Scientific Context

Both peptides emerged from extensive GH secretagogue research between 1980 and 2010. – **CJC-1295 (no DAC)** originated as a stabilized analog of GHRH (1-29), allowing precise short-acting GH pulse studies. – **Ipamorelin**, developed in the late 1990s by Novo Nordisk, became the most selective GHRP due to its ability to trigger GH release without affecting ACTH, cortisol, or prolactin levels. By the 2020s, their combination had become a benchmark reference in laboratory models examining GH pulsatility, pituitary feedback, and anabolic repair signaling.

Mechanistic Focus in Research

Scientific investigations of this peptide pair focus on synergistic GH modulation through two pathways: – **CJC-1295 (no DAC):** Direct stimulation of GHRH receptors, initiating GH pulse events. – **Ipamorelin:** Ghrelin receptor activation in the pituitary, amplifying the magnitude of GH release. The combination is valued in research for its controlled endocrine response, anabolic signal amplification, and consistency across comparative peptide studies.

Analytical Verification (COA)

Laboratory: Liquilabs s.r.o., Czechia
Batch Number: GF082025021
Date Published: 22 August 2025
Identity (RT): • Ipamorelin: 0.989 ± 0.005 confirmed by spectrum (991 ± 10)
• MOD GRF (1-29): 0.992 ± 0.005 confirmed by spectrum (982 ± 10)
Content: • Ipamorelin 4.56 mg ± 0.02 mg per vial
• MOD GRF (1-29) 5.15 mg ± 0.03 mg per vial
Purity: ≥ 99.8 % (both peptides)
Bioburden: Not detected (USP <61>)
Endotoxin: < 0.001 EU/mg (USP <85>)
Heavy Metals: Not detected (As, Pb, Cd, Hg, Ni, V, Co)

Research Applications

– GH pulsatility and synergy studies between GHRH and GHRP analogs – Pituitary and ghrelin receptor mechanism exploration – Endocrine response mapping and secretion timing models – Muscle recovery and anabolic signaling investigations

Grail Formula Quality – From 24PEPTIDES

Every Grail Formula peptide is independently verified by Liquilabs for identity, purity, and analytical consistency. Each batch is fully traceable and documented, ensuring reproducibility in professional research. All compounds are supplied as lyophilized powders for optimal long-term stability.

When you choose Grail Formula CJC-1295 no DAC + Ipamorelin 5mg/5mg…

…you receive a high-purity dual peptide complex, validated by Liquilabs s.r.o. (Czechia) for identity and purity (≥ 99.8%). Delivered as a complete research package — everything included to begin your study immediately in a controlled environment.

⚠ Research Use Only

This compound and all related materials are intended solely for scientific and laboratory research. They are not approved for diagnostic or therapeutic use and must not be self-administered. Always handle with appropriate protective equipment and follow institutional safety protocols.

Verified CJC-1295 (no DAC) + Ipamorelin dual peptide

Each peptide independently tested for identity and purity

COA verified by Liquilabs s.r.o. (Czechia)

Purity ≥ 99.8 %, no endotoxins or contaminants

Lyophilized (freeze-dried) for maximum stability

Delivered as a complete research package

For research use only

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.